Form 4 for TXG 10x Genomics, Inc.
Accepted 2024-02-26 00:00:00 ET · period of report 2024-02-22 · accession 0001610717-24-000092 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-26 | 2024-02-22 | TXG | Saxonov Serge | CEO, Dir | S - Sale | $46.34 | -2,821 | 847.6K | -0.3% | -$130.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-02-22 | S | D | 2,821 | $46.34 | 847,560 | D | — | — |